| 8 |
History of TB |
06/01/2022 |
|
| 15 |
Discovery of Anti TB Drugs |
06/01/2022 |
|
| 27 |
Palliative Care and Rehabilitation |
09/01/2022 |
|
| 35 |
Reducing TB Vulnerabilities |
09/01/2022 |
|
| 34 |
TB Vaccines |
09/01/2022 |
|
| 37 |
Structures for ACSM under NTEP |
09/01/2022 |
|
| 36 |
Principles of ACSM in NTEP |
09/01/2022 |
|
| 45 |
TB Surveillance |
09/01/2022 |
|
| 48 |
Evaluation |
09/01/2022 |
|
| 19 |
Operational Definitions in Case Finding |
09/01/2022 |
|
| 68 |
Serological Tests [Banned] |
09/01/2022 |
|
| 67 |
Tests for TB infection |
09/01/2022 |
|
| 66 |
Histopathological Tests |
09/01/2022 |
|
| 65 |
Radiological Images |
09/01/2022 |
|
| 72 |
Specimen collection and transportation documentation |
09/01/2022 |
|
| 71 |
Specimen Receipt |
09/01/2022 |
|
| 69 |
Specimen Collection for Diagnosis |
09/01/2022 |
|
| 73 |
Impact of COVID-19 on TB Elimination Efforts |
09/01/2022 |
|
| 31 |
Co-morbidity Management |
09/01/2022 |
|
| 76 |
IPC in Laboratories |
09/01/2022 |
|
| 42 |
Infrastructure |
09/01/2022 |
|
| 82 |
Nikshay LIMS |
09/01/2022 |
|
| 81 |
Nikshay Aushadi |
09/01/2022 |
|
| 85 |
RNTCP era |
09/01/2022 |
|
| 84 |
NTP era |
09/01/2022 |
|
| 83 |
Prechemotherapy Era |
09/01/2022 |
|
| 110 |
Agencies and Projects working with NTEP |
09/01/2022 |
|
| 101 |
Medical College Task Force Mechanism |
09/01/2022 |
|
| 61 |
TB Case classification in NTEP |
13/01/2022 |
|
| 161 |
Characteristics of good quality sputum sample |
25/01/2022 |
|
